Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Anondita Medi.
Quarter-by-quarter operating performance
Financials of Anondita Medi.
Annual income statement trend
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Sales + | 77 | 137 |
| Expenses + | 51 | 87 |
| Operating Profit | 26 | 51 |
| OPM % | 33% | 37% |
| Other Income + | 0 | 1 |
| Interest | 3 | 4 |
| Depreciation | 1 | 1 |
| Profit before tax | 22 | 47 |
| Tax % | 25% | 27% |
| Net Profit + | 16 | 34 |
| EPS in Rs | 11.88 | 18.49 |
| Dividend Payout % | 0% | 0% |
Financials of Anondita Medi.
Capital structure and asset base
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 13 | 18 |
| Reserves | 25 | 111 |
| Borrowings + | 27 | 34 |
| Other Liabilities + | 13 | 22 |
| Total Liabilities | 78 | 185 |
| Fixed Assets + | 14 | 84 |
| CWIP | 6 | 0 |
| Investments | 3 | 0 |
| Other Assets + | 55 | 101 |
| Total Assets | 78 | 185 |
Financials of Anondita Medi.
Operating, investing and financing cash movement
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Cash from Operating Activity + | -10 | 11 |
| Cash from Investing Activity + | -23 | -63 |
| Cash from Financing Activity + | 33 | 61 |
| Net Cash Flow | -0 | 9 |
| Free Cash Flow | -30 | -52 |
| CFO/OP | -38% | 28% |
Financials of Anondita Medi.
Working capital efficiency and return ratios
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Debtor Days | 127 | 138 |
| Inventory Days | 141 | 126 |
| Days Payable | 40 | 49 |
| Cash Conversion Cycle | 228 | 215 |
| Working Capital Days | 129 | 163 |
| ROCE % | 44% |
Quick commerce channel is rapidly growing, currently about 10% of revenues, with healthy economics and fastest-growing channel. Key concall takeaways from…
The company remains confident about maintaining 14%-15% PAT (profit after tax) growth at consolidated level if double-digit top-line growth continues. Key…
Recent quarters saw exponential growth: 20% YoY in FY26 and 28% YoY in Q1 FY27, partly due to prior price corrections and strategic actions (Nishita Shanklesha…
Premium segment is a key growth driver, growing 6 times faster than the market; significant opportunity remains as only 19% of toothpaste is currently premium…